Sebela Pharmaceuticals Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for Sebela Pharmaceuticals Inc.

Team Bitscale

24 Feb 2026 — 1 min read

Sebela Pharmaceuticals Inc.

Overview

This specialty pharmaceutical company, headquartered in Roswell, Georgia, has focused since 2013 on the commercialization and development of prescription products in Gastroenterology, Women's Health, and Dermatology. Their dedication centers on improving patient lives through innovative pharmaceutical solutions, leveraging research and development to provide market-leading therapies.

With expansions in Gastroenterology—particularly after acquiring Braintree Laboratories in 2018—Sebela enhances offerings in colonoscopy preparation products. Women's Health initiatives include tailored options such as a hormone-free, low-dose copper intrauterine device currently in Phase 3 trials. The Dermatology division deploys an internal sales force to market under-represented products and broaden its portfolio.

Basic Information

Industry	pharmaceuticals
Founded	2013
Revenue	6.2M
Headquarters	645 Hembree Pkwy, Suite I, Roswell, Georgia 30076-3868, United States
Languages	English

Contact Details

Phone: +1 844-732-3521
Website: sebelapharma.com
LinkedIn: linkedin.com/company/sebela-pharmaceuticals-llc

Key Focus Areas & Initiatives

Gastroenterology
Women's Health
Dermatology
Pharmaceutical manufacturing
Research and development
Colonoscopy prep products
NDA filings
Clinical trials
IUD innovations
Biotech
B2B services
Medical devices
Pipeline development
Oncology
Pharmaceutical development
Reflux disease therapies
Congenital therapies
Patient care
Phase 3 programs
Healthcare
GERD treatments
Cancer screening products
Contraceptive products
Manufacturing
Medical research
Health care
Health, wellness & fitness
Hospital & health care
Mechanical or industrial engineering

Technologies Used

ASP.NET
Amazon AWS
Bootstrap Framework
Google Tag Manager
Microsoft Office 365
Microsoft-IIS
Mimecast
Mobile Friendly
Oracle Cloud
Outlook
Remote
Slack

Affiliated Organizations & Regional Branches

Clay API Limits, Authentication & Rate Limits Explained

Your enrichment workflow ran perfectly on 50 test records. Then you pointed it at 10,000 contacts and everything collapsed: 429 errors, duplicate CRM writes, and a credit balance that evaporated overnight. The Clay API usually is not the root cause. The root cause is treating authentication, rate limits, and

GTM Data Stack for US Outbound Teams

Outbound has changed. Spray-and-pray cadences that worked five years ago now burn through contact lists, damage sender reputation, and leave revenue teams short on pipeline. What separates high-performing US outbound teams in 2026 is not effort or headcount. It is the quality, governance, and architecture of the GTM Data Stack.

GTM Automation for VC/PE-backed Startups

Every board deck at a VC or PE-backed startup tells the same story: aggressive revenue targets, intense board pressure after funding, and the need to make every dollar of runway count. Headcount alone doesn't fix pipeline math, especially with lean SDR teams. GTM automation (systematically automating target account

B2B Email List Providers Playbook: Build Clean, Compliant Lists That Actually Convert

In B2B sales, your email list is either a growth engine or a money pit. An outdated, irrelevant, or non-compliant database does not just fail to convert, it harms deliverability, wastes rep time, and increases risk across your GTM motion. That is why choosing B2B Email List Providers (and setting